These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31922304)

  • 1. Pressure-and dose-controlled, needle-free, transcutaneous pneumatic injection of botulinum neurotoxin-A for the treatment of primary axillary and palmoplantar hyperhidrosis.
    Kim HM; Lee MJ; Lee MH; Lee H
    Skin Res Technol; 2020 Jul; 26(4):577-583. PubMed ID: 31922304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.
    Rompel R; Scholz S
    J Eur Acad Dermatol Venereol; 2001 May; 15(3):207-11. PubMed ID: 11683282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis.
    Lee DG; Kim JE; Lee WS; Kim MB; Huh CH; Lee YW; Choi GS; Lee JB; Yu DS; Shin MK; Roh MR; Ahn HH; Kim WS; Lee JH; Park KY; Park J; Lee WJ; Park MY; Kang H
    Aesthetic Plast Surg; 2022 Jun; 46(3):1400-1406. PubMed ID: 35132458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.
    Lueangarun S; Sermsilp C; Tempark T
    Dermatol Surg; 2018 Aug; 44(8):1094-1101. PubMed ID: 29659406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.
    Glaser DA; Pariser DM; Hebert AA; Landells I; Somogyi C; Weng E; Brin MF; Beddingfield F
    Pediatr Dermatol; 2015; 32(5):609-17. PubMed ID: 26059781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
    Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
    Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox.
    Glogau RG
    Dermatol Surg; 1998 Aug; 24(8):817-9. PubMed ID: 9723044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical effects of botulinum toxin A and microwave thermolysis for axillary hyperhidrosis: A descriptive study with line-field confocal optical coherence tomography and histology.
    Grove GL; Jacobsen K; Maartensson NL; Haedersdal M
    Exp Dermatol; 2024 Jun; 33(6):e15110. PubMed ID: 38884423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
    Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
    Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
    Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
    Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
    Karamfilov T; Konrad H; Karte K; Wollina U
    Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Axillary hyperhidrosis: successful treatment with botulinum toxin A].
    Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
    Hautarzt; 1998 Feb; 49(2):101-3. PubMed ID: 9551330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Botulinum Toxin A-Coated Microneedles for Treating Palmar Hyperhidrosis.
    Shim DH; Nguyen TT; Park PG; Kim MJ; Park BW; Jeong HR; Kim DS; Joo HW; Choi SO; Park JH; Lee JM
    Mol Pharm; 2019 Dec; 16(12):4913-4919. PubMed ID: 31613636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S; Macaluso L; Salvi M; Luci C; Mattozzi C; Marzocca F; Salvo V; Scarnò M; Calvieri S; Richetta AG
    Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact.
    Lowe N; Naumann M; Eadie N
    Medicine (Baltimore); 2023 Jul; 102(S1):e32764. PubMed ID: 37499084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
    Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.